Last update: Aug. 14, 2020
Minimal risk for breastfeeding and infant.
Propafenone is a class Ic antiarrhythmic with some negative inotropic and beta-adrenoceptor blocking activity.
It is used in the management of supraventricular and ventricular arrhythmias.
Oral administration three times a day.
It is excreted in breast milk in clinically insignificant amounts (Wakaumi 2005, Libaron 1991).
In people who are slow metabolisers, the elimination half-life can be 10 to 32 hours.
Expert authors consider the use of the medication to be probably compatible during breastfeeding (Hale 2019, Briggs 2017).
We do not have alternatives for προπαφαινόνη υδοχλωρική since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.